GSTO2 and COVID-19: Analysis of 265 hospitalized patients showed no association between these variant genotypes and progression to severe COVID-19 after adjusting for inflammatory biomarkers and clinical covariates (OR = 1.33, p = 0.427 for GSTO1; OR = 1.05, p = 0.892 for GSTO2).